In contrast, the PGE2 degrading enzyme 15-PGDH is tumor suppressive, where its downregulation results in enhanced breast cancer cell proliferation, cell cycle entry in vitro, and enhanced tumorigenicity in vivo (28, 46, 53, 54). Here, HPGD is linked to breast carcinoma.